Skip to content
OpenCapital
Get started

Fabrinet FN Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Optical communications73.2%-2.9%
Non-optical communications26.8%+8.9%

Other financials

Income statement

See full
Revenue$1.2B+39.3%
Gross profit$144.3M+41.3%
Operating income$120.0M+52.2%
Net income$125.2M+54.0%
EPS (diluted)$3.45+53.3%

Balance sheet

See full
Cash & equivalents$357.3M+16.4%
Total debt$4.4M-22.7%
Total equity$2.3B+20.8%
Total assets$3.5B+34.0%

Cash flow

See full
Operating cash flow$52.9M-28.7%
CapEx$63.8M+124%
Free cash flow$57.3M-8.9%

Valuation

See full
Market cap$18.8B+96.6%
Enterprise value$18.45B+99.0%
P/E44.7×+15.9×
P/S4.4×+1.6×

Profitability

See full
Gross margin12%-0.1pp
Operating margin9.9%+0.4pp
Net margin9.9%-0.1pp
FCF margin5.6%-4.2pp

Returns & leverage

See full
Return on equity20%+1.7pp
Debt / equity0×0.0×
Current ratio2.5×-0.8×